Profusa
Developer of tissue-integrated, injectable hydrogel microsensors and associated optical readers and data systems for long-term, continuous monitoring of body chemistry. Products and programs include clinical tissue-oxygen monitoring (CE marked in the EU), development of long-duration glucose and multi-analyte sensors, wearable/patch reader development, and a cloud/AI data platform for secure clinical integration. Work has been supported by DARPA, NIH, and other grants.
Industries
Nr. of Employees
medium (51-250)
Patents
Optical filter device, system, and methods for improved optical rejection of high angle of incidence (AOI) light
US-12204125-B2
View Details
Optical filter device, system, and methods for improved optical rejection of high angle of incidence (AOI) light
US-12204125-B2
View DetailsProducts
Lumee Oxygen Platform
Integrated system comprising injectable oxygen-sensitive hydrogel biosensors, an injector, an external optical reader, and software for encrypted data capture and historical tracking of local tissue oxygen.
Lumee Oxygen Platform
Integrated system comprising injectable oxygen-sensitive hydrogel biosensors, an injector, an external optical reader, and software for encrypted data capture and historical tracking of local tissue oxygen.
Services
Co-development partnerships with academic centers and industry to develop readers, thin-film electronics, and clinical applications for implantable biosensors.
Support and execution of clinical studies for device evaluation and evidence generation in vascular interventions, wound care, and other intended-use scenarios.
Co-development partnerships with academic centers and industry to develop readers, thin-film electronics, and clinical applications for implantable biosensors.
Support and execution of clinical studies for device evaluation and evidence generation in vascular interventions, wound care, and other intended-use scenarios.
Expertise Areas
- Tissue-integrated biosensors
- Continuous biochemical monitoring
- Optical detection and tissue optics
- Clinical device evaluation for vascular and wound care
Key Technologies
- Injectable hydrogel microsensors
- Fluorescence-based luminescent sensing
- Optical reader technology
- Wearable thin-film electronics (patch readers)
News & Updates
Public demonstrations of biointegrated sensors and presentations on long-term continuous monitoring at CES and related events.
Media articles describing the injectable biosensor concept, continuous biochemical monitoring, and demonstrations at CES and other events.
Received CE Mark to market the tissue-oxygen monitoring platform in Europe.
Awarded $7.5M DARPA/ARO grant to develop implantable biosensors for simultaneous, continuous monitoring of multiple body chemistries.
Awarded $1.5M NIH Phase II SBIR grant in collaboration with NC State ASSIST Center to co-develop an ultrathin, wearable wireless oxygen monitor (bandage reader) for PAD patients.
Received a 2016 Edison Silver Award in the Health and Wellness – Wearable and Sensors category for tissue-integrating biosensor design and technology.
Public demonstrations of biointegrated sensors and presentations on long-term continuous monitoring at CES and related events.
Media articles describing the injectable biosensor concept, continuous biochemical monitoring, and demonstrations at CES and other events.
Received CE Mark to market the tissue-oxygen monitoring platform in Europe.
Awarded $7.5M DARPA/ARO grant to develop implantable biosensors for simultaneous, continuous monitoring of multiple body chemistries.
Awarded $1.5M NIH Phase II SBIR grant in collaboration with NC State ASSIST Center to co-develop an ultrathin, wearable wireless oxygen monitor (bandage reader) for PAD patients.
Received a 2016 Edison Silver Award in the Health and Wellness – Wearable and Sensors category for tissue-integrating biosensor design and technology.